Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

What’s holding up biosimilars in the US? Researchers investigate
Biopharma Reporter
Friday, January 31, 2014 - 8:21am
tags:
biosimilars
Novo reports growth for last year but tamps down expectations for this one
Fierce Pharma
Friday, January 31, 2014 - 8:17am
tags:
earnings, Novo Nordisk
Daiichi Sankyo pledges bold action on Ranbaxy production problems
Reuters
Friday, January 31, 2014 - 8:16am
tags:
drug manufacturing, Daiichi Sankyo, Ranbaxy
How Sangamo BioSciences, Inc. Is Partnering to Success
Motley Fool
Friday, January 31, 2014 - 8:15am
tags:
Sangamo BioSciences, zinc-finger proteins, Shire, Biogen Idec
6 Reasons Why Bristol-Myers Is A Good Immuno-Oncology Investment For 2014
Seeking Alpha
Friday, January 31, 2014 - 8:14am
tags:
oncology, immunotherapy, Bristol-Myers Squibb, melanoma, Yervoy
AbbVie 4th-quarter earnings slide, hit by generics competition
Yahoo/Reuters
Friday, January 31, 2014 - 8:13am
tags:
earnings, AbbVie
Despite Dilution, Aratana Therapeutics Can Keep Climbing
Motley Fool
Friday, January 31, 2014 - 8:12am
tags:
Aratana, animal health, AT-005
Amgen's cholesterol fighter succeeds in 5th late-stage study
Yahoo/Reuters
Friday, January 31, 2014 - 8:09am
tags:
Amgen clinical trials, evolocumab, familial hypercholesterolemia
Positive Data on Omeros' OMS824
Yahoo/Zacks.com
Friday, January 31, 2014 - 8:07am
tags:
Omeros, OMS824, schizophrenia
Sanofi sues Eli Lilly over patents for top-selling insulin drug
Yahoo/Reuters
Friday, January 31, 2014 - 8:06am
tags:
Sanofi, Eli Lilly, insulin, diabetes, Lantus
Is AbbVie (ABBV) Poised to Beat Earnings Estimates?
Yahoo/Zacks.com
Thursday, January 30, 2014 - 2:51pm
tags:
earnings, AbbVie
Eyes Down For GlaxoSmithKline plc’s Results
Motley Fool
Thursday, January 30, 2014 - 11:54am
tags:
GSK, earnings
Alexion Pharma Skips Out on Paying U.S. Taxes, Wall Street Says Hurrah!
TheStreet.com
Thursday, January 30, 2014 - 11:52am
tags:
Alexion, Ireland
4Q Earnings, Revs Beat by Zimmer
Yahoo/Zacks.com
Thursday, January 30, 2014 - 11:41am
tags:
Zimmer, devices, earnings
New British biotech firm to tap gene therapy for blindness
Reuters
Thursday, January 30, 2014 - 10:20am
tags:
NightstaRx, retinal distrophies, blindness
Progenics tanks after two trial deaths cast doubt on its lead program
Fierce Biotech
Thursday, January 30, 2014 - 10:18am
tags:
Progenics, PSMA ADC, prostate cancer
KaloBios calls it quits on its asthma drug after a Phase II flop
Fierce Biotech
Thursday, January 30, 2014 - 10:17am
tags:
asthma, KaloBios, KB003
The top 10 largest pharma layoffs in 2013
Fierce Pharma
Thursday, January 30, 2014 - 10:16am
tags:
layoffs
Novartis’ Fourth Quarter Earnings: 3 Key Takeaways
Motley Fool
Thursday, January 30, 2014 - 10:14am
tags:
Novartis, earnings
One-Time Gains Propel Vertex to a Profit in Q4 As Incivek Sales Plummet
Motley Fool
Thursday, January 30, 2014 - 10:12am
tags:
earnings, Vertex Pharmaceuticals

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.